Optimizing LZK-targeting PROTACs will be extremely important going forward to achieve efficacy at low nanomolar concentrations as LZK depletion completely abrogates colony formation in HNSCC cell with amplified MAP3K13. The gene discussed is MAP3K13; the disease is head and neck squamous cell carcinoma.